|WHEN||June 08, 2013 @ 8:00am - 5:00pm|
Date: June 8th, 2013, 8:00am – 4:45pm
Location: Hilton, San Diego/Del Mar
Directions: Go to the bottom of page
$30 for online registration before midnight of June 5, $50 for onsite registration, students and postdocs $10 off (The fees include parking at the hotel, program brochure, continental breakfast, coffee break, and lunch). Online registration closes on June 5th.
Organizer: Sino-American Biomedical & Pharmaceutical Professionals Association (SABPA)
Sino-American Biotechnology and Pharmaceutical Professionals Association (SABPA) is a local non-profit professional organization (https://www.sabpa.org). At this year’s San Diego Bio-Pharma Conference, we bring together top-notched speakers to discuss recent breakthroughs in life science and latest industry trends on a global scale. We are also putting together a very rare and exciting drug discovery panel representing elite local companies with drugs that have recently gained FDA approvals to showcase San Diego’s drug discovery success stories. The program is guaranteed to generate sizzling discussion and stimulate new ideas with renewed enthusiasm of investing in San Diego biotech.
|8:00 am||Exhibition (all day)|
|8:00 am||Continental Breakfast & Registration|
|8:45 am||Opening Remarks
Mingzhu Zhang, President, SABPA San Diego
Mao Mao, Research Fellow, Pfizer, Inc
|9:00 am||Keynote Speech: Personalized Medicine in Complex Human Disease: A Cautionary Tale
Gary S. Firestein, M.D., Director, Clinical and Translational Research Institute.
The Dean and Associate Vice Chancellor, Translational Medicine, UC San Diego
|9:40 am||Session I. Drug Discovery in the Post-Genomic Era
Session Chair: Wendy Wang, Sr. Engineer, Genoptix
Title: Innovating in Peptide and Protein Therapeutic Space: Recent Progress and Future
Keith James, Ph.D., President, Ferring Research Institute.
Sr. VP, R&D, Ferring Pharmaceuticals
Title: Maximizing Success of Drug development by Optimal Patient Stratification
Shabnam Tangri, Ph.D., Executive Director, Genoptix.
Head, Clinical Trial Center of Exellence, Genoptix
|10:40 am||Coffee Break
|11:00 am||Session II (Plenary Discussion): Made in San Diego
Moderator: Jonathan Lim, M.D., CEO, Ignyta; Managing Partner, City Hill Ventures
Jean Cui, Ph.D., Associate Research Fellow, Pfizer Inc.
Jack Lief, CEO, Arena Pharmaceuticals Inc.
Larry Z. Shen, Ph.D., VP, Corporate Analytics, Amylin Pharmaceuticals, LLC, a Bristol-Myers Squibb Company
Wendell Wierenga, Ph.D., Executive Vice President, R&D, Santarus
Ashley Van Zeelan, Ph.D., Co-Founder and CEO, Cypher Genomics
|1:30 pm||San Diego Bio-Pharma Achievement Award
Moderator: Ming Guo, Vice President, Ascentage Pharma
Award Recipients: Jack Lief, CEO, Arena Pharmaceuticals
|1:40 pm||Session III: Charting a New Course for Innovations
Session Chair: JC Xu, Director, Biology, Quanticel Pharmaceuticals
|1:45 pm||Title: Creating a Successful Biotech Company … a Work in Progress
Jack Lief, Ph.D., CEO of Arena Pharmaceuticals Inc.
|2:15pm||Title: CTI: A New Model for Accelerating Translation of Basic Academic Science to the
Richard A. Lindberg, Ph.D., Executive Director and Head of the Centers for Therapeutic Innovation-
Title: Life Sciences VC Financing in China & India
Justin Chakma, B.Sc., Analyst, Thomas, McNerny & Partners
|3:10 pm||Coffee Break|
|3:30 pm||Session IV Plenary Discussion: Innovations in China
Moderator: Xiao Xu, President, ACEA Biosciences Inc.
Shiang Huang, M.D., Founder and CEO, Kindstar Global
Youling Wu, Ph.D., CEO, Teruisi Pharmaceutical Inc.
Tracy T. Yeo, Ph.D., Director, Consulting at ChinaBio, LLC
Xiaokun Zhang, Ph.D., Professor and Dean, Institute of Biomedical Research, Xiamen
University; Professor, Sanford-Burnham Medical Research Institute, USA
|4:45 pm||Closing Remark
Hui Li, Ph.D., Chair, Board of Directors, SABPA
Previous Events: www.sdbiopharma.org